Karl-Heinz Kuck, Asklepios Klinik St Georg, Hamburg, Germany, speaks at ACC 2016 about the FIRE AND ICE trial results which have shown that cryoballoon ablation is non-inferior to radiofrequency ablation in treating patients with drug-refractory paroxysmal atrial fibrillation, with no significant overall safety difference between the two methods.
